Trial Profile
Postoperative Pain Control After Enucleation or Evisceration, a Double-Masked Randomized Controlled Trial of Standard Versus Slow-release Bupivacaine
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2024
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 06 Apr 2024 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.
- 06 Apr 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2024.
- 11 Mar 2022 Planned number of patients changed from 100 to 70.